The Transformation Of Sanofi-Aventis U.S.
By Dan Schell, Chief Editor, Clinical Leader
The exclusive Life Science Leader interview with Gregory Irace, president and CEO of Sanofi-Aventis U.S.
What specific changes do you see as inevitable regarding how pharma companies must operate in the future?
Two come to mind. First, pharma companies must do a better job demonstrating to customers the value of our products on the customer’s own terms. The old model of telling customers why we believe they should use our products is less and less effective. Second, we must face the reality that no matter what changes occur externally, we will be operating with smaller margins in the future.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.